xconomy.com xconomy.com - Le score est de 60/100

Evaluation du site xconomy.com

 Généré le 15 Octobre 2026 13:45

Vieilles statistiques? UPDATE !

Le score est de 60/100





Advertisement

Optimisation du contenu

Titre

BioXconomy

Longueur : 10

Idéalement, votre titre devrait contenir entre 40 et 70 caractères (espaces compris). Utilisez cet outil gratuit pour calculer la longueur du texte.

Description

BioXconomy provides information and insights for life sciences investment, innovation and partnering.

Longueur : 101

Génial, votre balise META description contient entre 90 et 160 caractères.

Mots-clefs

Très mauvais. Nous n'avons pas trouvé de balise META keywords sur votre page. Utilisez ce générateur gratuit de balises META en ligne pour créer des mots-clés.

Propriétés Open Graph

Bien, cette page profite des balises META Open Graph.

Propriété Contenu
title BioXconomy
description BioXconomy provides information and insights for life sciences investment, innovation and partnering.
url https://www.bioxconomy.com/
type website
image https://eu-images.contentstack.com/v3/assets/blt72fb3b8b4630b7db/blt25617c776391716f/6a7e58393f96871c9f61f984/BioXconomy-opengraph-2.jpg?disable=upscale&width=1200&height=630&fit=crop
site_name BioXconomy

Niveaux de titre

H1 H2 H3 H4 H5 H6
0 3 9 8 4 0
  • [H2] Latest News
  • [H2] Blood-brain barrier repair peptide could hold promise for ALS patients
  • [H2] Blood-brain barrier repair peptide could hold promise for ALS patients
  • [H3] IgniteData, RealTime eClinical Solutions announce data transfer partnership
  • [H3] OMass bags $310m to push rare disease drugs forward
  • [H3] Zealand Pharma generates metabolic therapeutics with AI platform
  • [H3] Bluesky and X users share clinical trial information in markedly different ways, new research shows
  • [H3] Dose of Discovery Podcast, Season 1
  • [H3] Watch the latest presentations coming from our recent partnering events
  • [H3] News from APAC
  • [H3] Interviews
  • [H3] AI in Life Sciences
  • [H4] Related Topics
  • [H4] Recent in Partnering
  • [H4] Related Topics
  • [H4] Recent in Investment
  • [H4] Related Topics
  • [H4] Recent in Modalities
  • [H4] Related Topics
  • [H4] Recent in Business Strategy
  • [H5] Resources
  • [H5] Connect
  • [H5] Join Us
  • [H5] Follow Us

Images

Nous avons trouvé 54 image(s) sur cette page Web.

4 attribut(s) alt sont vides ou manquants. Ajouter un texte alternatif permet aux moteurs de recherche de mieux comprendre le contenu de vos images.

Ratio texte/HTML

Ratio : 3%

le ratio de cette page texte/HTML est au-dessous de 20 pour cent, ce qui signifie que votre site manque de contenu textuel.

Iframe

Dommage, vous avez des Iframes sur vos pages Web, cela signifie que son contenu ne peut pas être indexé par les moteurs de recherche.

Réécriture d'URLs

Bien. Vos liens sont optimisés!

Tiret bas dans les URLs

Parfait! Aucuns soulignements détectés dans vos URLs.

Liens dans la page

Nous avons trouvé un total de 73 lien(s) dont 0 lien(s) vers des fichiers

Texte d'ancre Type Juice
Informa PLC Externe Passing Juice
ABOUT US Externe Passing Juice
INVESTOR RELATIONS Externe Passing Juice
TALENT Externe Passing Juice
About Interne Passing Juice
Events Interne Passing Juice
Advertise Externe Passing Juice
Licensing Interne Passing Juice
M&A Interne Passing Juice
Growth Strategy Interne Passing Juice
Partnering Interne Passing Juice
Zealand Pharma generates metabolic therapeutics with AI platform Interne Passing Juice
Nnenna Ohaka Interne Passing Juice
Danaher and NVIDIA partner on AI-driven lab automation Interne Passing Juice
Millie Nelson Interne Passing Juice
VC/PE Interne Passing Juice
Seed Funding Interne Passing Juice
IPOs Interne Passing Juice
Investment Interne Passing Juice
OMass bags $310m to push rare disease drugs forward Interne Passing Juice
Stryker bets big on robot surgery, backing CMR Surgical in $400m deal Interne Passing Juice
Nucleic Acids Interne Passing Juice
Antibodies and Peptides Interne Passing Juice
Advanced Therapies Interne Passing Juice
Modalities Interne Passing Juice
Rethinking Expression to Accelerate Antibody Discovery Interne Passing Juice
Blood-brain barrier repair peptide could hold promise for ALS patients Interne Passing Juice
Søren Hough Interne Passing Juice
Compliance, Regulatory and Legal Interne Passing Juice
Access and Channel Interne Passing Juice
Finance and Accounting Interne Passing Juice
Clinical Trials Interne Passing Juice
Pricing and Contracting Interne Passing Juice
Business Strategy Interne Passing Juice
Optimizing the Affordability Journey: Insights from a Real-World Brand Case Study Interne Passing Juice
IgniteData, RealTime eClinical Solutions announce data transfer partnership Interne Passing Juice
EMA to make EU-level trial advice pilot a permanent option for sponsors Interne Passing Juice
Dose of Discovery: Katalin Karikó on the mRNA breakthrough that changed medicine Interne Passing Juice
Dose of Discovery: Anne Conibear on how small changes reshape peptide and protein biology Interne Passing Juice
Dose of Discovery: Erik Sontheimer on the evolution of genome editing Interne Passing Juice
Dose of Discovery: Cheng Yi Chen on scaling drugs from lab to launch Interne Passing Juice
Dose of Discovery: Stanley Crooke on fixing nano-rare disease with oligos Interne Passing Juice
Dose of Discovery: Julia Alterman on expanding RNA therapeutics Interne Passing Juice
Dose of Discovery: Debut trailer Interne Passing Juice
Eyes on Asia: TCGX, Biohaven, Roche Interne Passing Juice
Shionogi bolsters rare disease portfolio with $2bn IntraBio buy Interne Passing Juice
The hidden cost of going global: How most favored nation pricing is reshaping rare disease launches Interne Passing Juice
Brandy Fidler Interne Passing Juice
SEC-FDA pact tightens disclosure rules for pharma Interne Passing Juice
Lisa Henderson Interne Passing Juice
Medtech firms embrace embedded digital compliance Interne Passing Juice
Tarn Brown Interne Passing Juice
DaltonTx announces AI breakthrough in novel antibody discovery Interne Passing Juice
Millie Hoe Interne Passing Juice
HHS launches initiative to bolster US clinical trials market Interne Passing Juice
Gareth Macdonald Interne Passing Juice
Protect IP theft from vast datasets used in AI Interne Passing Juice
Recruitment challenges, delays, and AI reshaping trials sector, survey finds Interne Passing Juice
Veeva unveils AI agent to speed clinical trial study configuration Interne Passing Juice
Rethinking biotech investment and innovation in a productivity-driven era Interne Passing Juice
Brick by brick: How AI-native biotechs are building investor confidence Interne Passing Juice
How AI is streamlining patient support behind the scenes Interne Passing Juice
AI drug hunter Iambic files for Nasdaq IPO Interne Passing Juice
Enveda’s $311m Series E to fund AI-driven drug discovery Interne Passing Juice
Webinars Interne Passing Juice
Podcasts Interne Passing Juice
Innovation Showcase Interne Passing Juice
Partner Videos Interne Passing Juice
Contribute Interne Passing Juice
About Informa Externe Passing Juice
Contact Informa Externe Passing Juice
Privacy Externe Passing Juice
Terms Externe Passing Juice
Advertisement

Mots-clefs

Nuage de mots-clefs

min      read      dose      playarrow      presents      lsx      now      chevronright      discovery      oct     

Cohérence des mots-clefs

Mot-clef Contenu Titre Mots-clefs Description Niveaux de titre
oct 22
discovery 22
lsx 21
min 20
presents 19

Ergonomie

Url

Domaine : xconomy.com

Longueur : 11

Favicon

Génial, votre site web dispose d'un favicon.

Langue

Bien. Votre langue est : en.

Document

Doctype

HTML 5

Encodage

Parfait. Votre charset est UTF-8.

E-mail confidentialité

Génial, aucune adresse e-mail n'a été trouvé sous forme de texte!

HTML obsolètes

Génial! Nous n'avons pas trouvé de balises HTML obsolètes dans votre code.

Astuces vitesse

Mauvais, votre site web utilise des styles css inline.
Mauvais, votre site web contient trop de fichiers CSS (plus de 4).
Parfait, votre site web contient peu de fichiers javascript.
Parfait : votre site tire parti de gzip.

Mobile

Optimisation mobile

Icône Apple
Méta tags viewport
Advertisement

Optimisation

Sitemap XML

Votre site web dispose d’une sitemap XML, ce qui est optimal.

https://www.bioxconomy.com/sitemap.xml
https://www.bioxconomy.com/googlenews.xml
https://www.bioxconomy.com/contributors.xml
https://www.bioxconomy.com/generic-content.xml
https://www.bioxconomy.com/image-archive-index.xml
https://www.bioxconomy.com/news-archive-index.xml
https://www.bioxconomy.com/event-archive-index.xml
https://www.bioxconomy.com/articles-archive-index.xml
https://www.bioxconomy.com/videos-archive-index.xml
https://www.bioxconomy.com/webinar-archive-index.xml
https://www.bioxconomy.com/podcast-archive-index.xml
https://www.bioxconomy.com/multi-section-article-archive-index.xml
https://www.bioxconomy.com/publication-issue-archive-index.xml
https://www.bioxconomy.com/document-archive-index.xml
https://www.bioxconomy.com/sitemap-index.xml
https://www.bioxconomy.com/ads.txt

Robots.txt

http://xconomy.com/robots.txt

Votre site dispose d’un fichier robots.txt, ce qui est optimal.

Mesures d'audience

Manquant

Nous n'avons trouvé aucun outil d'analytics sur ce site.

Un outil de mesure d'audience vous permet d'analyser l’activité des visiteurs sur votre site. Vous devriez installer au moins un outil Analytics. Il est souvent utile d’en rajouter un second, afin de confirmer les résultats du premier.

AI Search Readiness

AI Crawlers

AI search crawlers are allowed, so the site can be shown and cited in AI answers (ChatGPT, Claude, Perplexity).

OAI-SearchBot ChatGPT search AI search
ChatGPT-User ChatGPT (user requests) AI search
Claude-SearchBot Claude search AI search
Claude-User Claude (user requests) AI search
PerplexityBot Perplexity AI search
GPTBot OpenAI training AI training
ClaudeBot Anthropic training AI training
Google-Extended Google Gemini training AI training
Applebot-Extended Apple AI training AI training
CCBot Common Crawl AI training

Blocking AI training crawlers is a common choice and doesn't affect the score. Only the AI search crawlers count.

Structured Data

The homepage describes itself with schema.org structured data, which helps search engines and AI tools understand it: NewsMediaOrganization, ImageObject, QuantitativeValue

Canonical Tag

The homepage has a canonical tag, which tells search engines which URL is the main version of the page.

llms.txt

No llms.txt file. It's an emerging convention: a short Markdown summary of the site for AI tools. Optional, so it doesn't affect the score.

Security

HTTPS

The site loads over HTTPS, so connections are encrypted. Browsers and search engines expect this.

HSTS

The site sends a Strict-Transport-Security header, so browsers always use HTTPS for it.

Security Headers

1 of 5 common security headers found. At least 2 are needed to pass.

Content-Security-Policy
X-Content-Type-Options
X-Frame-Options
Referrer-Policy
Permissions-Policy
Checked on 15 Oct 2026.

Domain Info

xconomy.com was registered on 25 Aug 2006 with SafeNames Ltd. and expires on 25 Aug 2027. It has no mail server (MX) records. The Wayback Machine first archived it in April 2001.

Registration

Registrar SafeNames Ltd.
Registered 25 Aug 2006 (20 years ago)
Expires 25 Aug 2027
Last changed 25 Aug 2026
Nameservers james.ns.cloudflare.com, marge.ns.cloudflare.com
DNSSEC Signed

Hosting

IPv4 address 172.67.128.87, 104.21.0.223
IPv6 support

Email Security

This domain has no mail server (MX) records, so it doesn't receive email.

SPF record
DMARC record (policy: quarantine)

Archive History

The Wayback Machine has snapshots of this site from 189 different months, from April 2001 to February 2026. View snapshots

Domain data checked on 15 Oct 2026. Sources: registry RDAP, public DNS, Internet Archive.

PageSpeed Insights

Dispositif
Les catégories
Advertisement

GoInfosystems

GoInfosystems est un outil gratuit de référencement qui vous aidera à analyser vos pages web